Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» rilzabrutinib
rilzabrutinib
Sanofi reports positive data from Phase II asthma treatment trial
Clinical Trials Arena
Thu, 05/23/24 - 10:58 am
Sanofi
clinical trials
rilzabrutinib
asthma
Sanofi's New Cancer Drug Could Help Deliver a Big Payday
Motley Fool
Wed, 05/8/24 - 11:34 am
Sanofi
rilzabrutinib
Btk inhibitors
clinical trials
Sanofi gears up for approval of its BTK inhibitor, meets Phase III endpoint
Clinical Trials Arena
Tue, 04/23/24 - 10:51 am
Sanofi
rilzabrutinib
Btk inhibitors
ITP
Sanofi looks to advance CSU drug rilzabrutinib in Phase III trial
Clinical Trials Arena
Mon, 02/26/24 - 10:35 am
Sanofi
rilzabrutinib
chronic spontaneous urticaria
clinical trials
Sanofi’s Principia purchase fails its first test
EP Vantage
Thu, 09/9/21 - 10:53 am
Sanofi
rilzabrutinib
Principia Biopharma
clinical trials
pemphigus vulgaris
Rilzabrutinib granted FDA fast track designation for treatment of immune thrombocytopenia
Pharmaceutical Business Review
Thu, 11/19/20 - 10:40 am
rilzabrutinib
fast track
FDA
Sanofi
Principia Biopharma
chronic immune thrombocytopenia